Solid Biosciences Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2015 | — | — | $28.6M |
| Dec 2016 | — | — | $7.7M |
| Mar 2017 | — | — | $29.3M |
| Jun 2017 | — | — | $32.7M |
| Sep 2017 | — | — | $15.0M |
| Dec 2017 | $11.3M | $76.2M | $52.1M |
| Mar 2018 | $10.3M | $189.2M | $164.8M |
| Jun 2018 | $9.2M | $171.5M | $145.8M |
| Sep 2018 | $11.7M | $156.8M | $129.1M |
| Dec 2018 | $14.4M | $139.6M | $86.4M |
| Mar 2019 | $21.1M | $120.2M | $54.0M |
| Jun 2019 | $19.8M | $96.3M | $51.8M |
| Sep 2019 | $22.4M | $130.9M | $94.7M |
| Dec 2019 | $23.4M | $103.5M | $76.0M |
| Mar 2020 | $17.5M | $74.0M | $53.2M |
| Jun 2020 | $17.3M | $58.0M | $40.4M |
| Sep 2020 | $18.3M | $40.5M | $24.8M |
| Dec 2020 | $39.1M | $171.2M | $154.7M |
| Mar 2021 | $32.3M | $285.3M | $268.5M |
| Jun 2021 | $27.9M | $265.9M | $200.6M |
| Sep 2021 | $25.6M | $249.0M | $109.7M |
| Dec 2021 | $24.2M | $232.4M | $119.1M |
| Mar 2022 | $22.0M | $207.6M | $129.7M |
| Jun 2022 | $46.3M | $208.5M | $54.3M |
| Sep 2022 | $41.2M | $184.5M | $48.8M |
| Dec 2022 | $48.6M | $260.3M | $155.4M |
| Mar 2023 | $45.8M | $229.6M | $164.6M |
| Jun 2023 | $41.0M | $204.7M | $91.6M |
| Sep 2023 | $40.4M | $184.7M | $49.0M |
| Dec 2023 | $38.5M | $164.9M | $74.0M |
| Mar 2024 | $38.0M | $248.7M | $117.6M |
| Jun 2024 | $37.7M | $231.0M | $95.9M |
| Sep 2024 | $44.8M | $211.8M | $64.4M |
| Dec 2024 | $51.4M | $188.7M | $80.2M |
| Mar 2025 | $49.4M | $343.9M | $210.6M |
| Jun 2025 | $50.0M | $308.3M | $138.9M |
| Sep 2025 | $56.0M | $273.9M | $61.4M |
| Dec 2025 | $52.5M | $232.5M | $59.9M |
| Mar 2026 | $48.8M | $422.9M | $297.1M |
| Jun 2026 | $46.5M | $420.6M | $159.4M |